Fluorescence Polarization Assays
| Category | Methods |
|---|---|
| Also known as | FP Assay, Fluorescence Anisotropy |
| Last updated | 2026-04-14 |
| Reading time | 5 min read |
| Tags | methodsbindinghigh-throughput |
Overview
Fluorescence polarization (FP) assays measure binding by exploiting the relationship between molecular rotation and the polarization of emitted fluorescence. Small, rapidly tumbling fluorescent peptides emit depolarized light; when bound to a larger target, rotation slows and the light remains polarized. The resulting polarization signal tracks binding quantitatively.
FP is a homogeneous (no wash) assay that runs in microplates with a simple fluorescence reader โ making it a workhorse for medium-throughput screening and dissociation constant determination. It complements label-free methods like surface plasmon resonance with faster readout and lower cost.
Principles
When a fluorophore is excited with polarized light, it emits fluorescence whose polarization depends on molecular rotation between excitation and emission. Three regimes:
- Free tracer โ small, fast rotation โ depolarized emission, low FP value
- Bound tracer โ slow rotation โ polarized emission, high FP value
- Intermediate states โ proportional mixture
Fluorescence polarization (P) and anisotropy (r) are related:
P = (I_parallel - I_perpendicular) / (I_parallel + I_perpendicular) r = (I_parallel - I_perpendicular) / (I_parallel + 2ยทI_perpendicular)
Both are dimensionless; FP is typically reported in millipolarization units (mP).
Assay Formats
Direct binding
- Fluorescently labeled peptide tracer at a fixed concentration
- Titrate target (receptor, protein, antibody) from low to high concentration
- Fit FP vs. [target] to extract Kd
Competition
- Fix tracer + target at concentrations producing 60โ80% bound
- Titrate unlabeled competitor
- Fit FP decrease vs. competitor to extract Ki
Most library screens and SAR studies use the competition format because it allows testing thousands of unlabeled compounds against one labeled tracer.
Mix-and-read screens
- All reagents added at once; read after short incubation
- Excellent for high-throughput (384- or 1536-well plates)
- No wash steps means no loss of low-affinity binders
Tracer Design
Fluorophore choice
- Fluorescein (FITC, FAM) โ classic, but pH-sensitive and photobleachable
- TAMRA, Alexa dyes โ brighter, more stable alternatives
- BODIPY, NBD โ environment-sensitive; can distort binding
- Red/far-red dyes (Cy5, Alexa 647) โ better for complex matrices
Labeling position
- N-terminus most common โ accessible and typically noncritical
- C-terminus alternative
- Side chain labeling via lysine or cysteine for specific orientation control
- See peptide labeling for chemistry options
Tracer validation
Before using a new tracer:
- Confirm identity and purity by mass spec analysis and HPLC
- Measure tracer alone FP value (free baseline)
- Confirm Kd in direct binding matches unlabeled peptide activity (if possible)
- Test tracer stability over assay timescale
Experimental Protocol
Reagents
- Fluorescent tracer (typically 1โ10 nM)
- Target protein (serial dilution from high to low concentration)
- Assay buffer: 20 mM Tris or HEPES, pH 7.5, 150 mM NaCl, 0.01% Triton or Tween, optional 1 mg/mL BSA
- Black flat-bottom microplates (384- or 1536-well)
- Competitor compound library for competition format
Procedure
- Prepare tracer solution at 2ร working concentration in assay buffer
- Prepare target dilution series at 2ร working concentration
- For competition format, prepare competitor dilution series at 4ร
- Add 25 ฮผL tracer + 25 ฮผL target (or target+competitor) per well
- Mix gently, incubate 15โ60 min at room temperature
- Read FP in multimode plate reader
- Subtract buffer-only and tracer-only controls if needed
Plate reader settings
- Excitation wavelength matched to fluorophore (e.g., 485 nm for fluorescein)
- Emission matched (e.g., 528 nm for fluorescein)
- Polarizers on excitation and emission; record parallel and perpendicular signals
Data Analysis
Direct binding
Fit fraction bound vs. [target]:
FP = FP_free + (FP_bound - FP_free) ร [T] / (Kd + [T])
Approximation valid when tracer concentration << Kd. For higher tracer concentrations, use tight-binding equation.
Competition
Fit FP vs. log[competitor] to a sigmoid dose-response. Extract IC50, then convert to Ki via Cheng-Prusoff:
Ki = IC50 / (1 + [Tracer]/Kd_tracer)
Quality metrics
- Signal window (FP_bound - FP_free) should be โฅ 50 mP for robust screening
- Z' โฅ 0.5 for HTS
- CV < 10% for replicate wells
- Linear dose-response over reasonable concentration range
Common Issues
Tracer aggregation
- Produces high background FP, masks binding
- Mitigation: filter tracer, add surfactant, check peptide aggregation
Inner filter effects
- High tracer or compound concentrations absorb excitation/emission, lowering measured signal
- Mitigation: lower tracer concentration, confirm linear range
Autofluorescent compounds
- Library compounds may fluoresce in the detection channel
- Mitigation: include compound-only controls, use red-shifted tracers
Nonspecific binding
- Compounds bind tracer directly rather than competing at target site
- Mitigation: orthogonal confirmation via SPR or ELISA
Plate effects
- Edge wells show drift due to evaporation or temperature gradients
- Mitigation: skip edge wells or equilibrate plates before reading
Applications
Hit identification
FP screens routinely test 10,000โ100,000 compounds against peptide or protein targets. Low false-positive rates compared to ELISA and no wash steps are major advantages.
SAR optimization
Compare Ki values across peptide analogs to drive structure-activity relationships.
Peptide library screening
Paired with focused libraries of peptide analogs โ see peptide library screening.
Biochemical mechanism studies
- Inhibitor class (competitive vs. non-competitive) inferred from full curves
- Cooperativity from Hill coefficients
Limitations
- Requires fluorescent tracer โ not every system has a convenient one
- Molecular weight difference between free and bound tracer must be โฅ 5โ10ร for good signal
- Compounds with fluorescence quenching or enhancement can confound results
- Not suitable for very large targets (polarization saturates at high MW)
Complementary Techniques
- Surface plasmon resonance โ orthogonal label-free confirmation
- ELISA for peptides โ heterogeneous confirmation
- Isothermal titration calorimetry โ thermodynamics
- MicroScale Thermophoresis (MST) โ alternative solution-based assay
Summary
Fluorescence polarization assays deliver high-quality binding data in microplate format with minimal reagent consumption. With a thoughtfully designed tracer, well-tuned protocol, and orthogonal validation of hits, FP is a versatile tool for hit identification, SAR optimization, and mechanistic studies throughout peptide drug development.
Related entries
- Binding Affinityโ A quantitative measure of how strongly a ligand binds its target, usually expressed as the dissociation constant (Kd) or its reciprocal association constant (Ka).
- Dissociation Constantโ The equilibrium concentration of free ligand at which half of the available binding sites are occupied โ a direct and intuitive measure of binding strength.
- ELISA for Peptidesโ Immunoassay protocols for detecting and quantifying peptides in biological samples โ direct, indirect, sandwich, and competition formats, with sensitivity optimization.
- Peptide Labelingโ Techniques for attaching detectable tags to peptides โ fluorophores, radioisotopes, biotin, affinity handles โ to track their fate in binding assays, imaging, and pharmacokinetic studies.
- Peptide Library Screeningโ Strategies for constructing and screening peptide libraries to discover binders, inhibitors, and functional modulators โ covering synthetic libraries, phage display, mRNA display, and downstream validation.
- Surface Plasmon Resonanceโ Label-free biosensor technique for measuring real-time binding interactions โ association rate, dissociation rate, and equilibrium constant โ of peptides and their targets.
- Dissociation Constant (Kd)โ The dissociation constant (Kd) is the concentration at which half of a receptor's binding sites are occupied by a ligand, quantifying binding affinity.